Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin C Thomas

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
The Journal of Medical Investigation : JMI|March 6, 2008
Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitusAndrzej S Januszewski, Merlin C Thomas, Connie S Karschimkus, et al.
Journal of the American Society of Nephrology : JASN|July 31, 2004
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end productsMarkus Lassila, Kwee K Seah, Terri J Allen, et al.
Diabetes Care|July 27, 2005
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study)Lena M Thorn, Carol Forsblom, Johan Fagerudd, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2017
Resveratrol Inhibits Growth of Experimental Abdominal Aortic Aneurysm Associated With Upregulation of Angiotensin-Converting Enzyme 2Corey S Moran, Erik Biros, Smriti M Krishna, et al.
Diabetes|June 16, 2012
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout miceAnna M D Watson, Stephen P Gray, Li Jiaze, et al.
Circulation Research|July 31, 2010
Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouseMerlin C Thomas, Raelene J Pickering, Despina Tsorotes, et al.
Diabetes|October 29, 2002
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathyJosephine M Forbes, Mark E Cooper, Vicki Thallas, et al.
American Journal of Physiology. Renal Physiology|December 18, 2009
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathyAdeline L Y Tan, Karly C Sourris, Brooke E Harcourt, et al.
Clinical Science (London, England : 1979)|December 11, 2012
Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetesChris Tikellis, Raelene J Pickering, Despina Tsorotes, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathyJosephine M Forbes, Suzanne R Thorpe, Vicki Thallas-Bonke, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
The Journal of Medical Investigation : JMI|March 6, 2008
Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitusAndrzej S Januszewski, Merlin C Thomas, Connie S Karschimkus, et al.
Journal of the American Society of Nephrology : JASN|July 31, 2004
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end productsMarkus Lassila, Kwee K Seah, Terri J Allen, et al.
Diabetes Care|July 27, 2005
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study)Lena M Thorn, Carol Forsblom, Johan Fagerudd, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2017
Resveratrol Inhibits Growth of Experimental Abdominal Aortic Aneurysm Associated With Upregulation of Angiotensin-Converting Enzyme 2Corey S Moran, Erik Biros, Smriti M Krishna, et al.
Diabetes|June 16, 2012
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout miceAnna M D Watson, Stephen P Gray, Li Jiaze, et al.
Circulation Research|July 31, 2010
Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouseMerlin C Thomas, Raelene J Pickering, Despina Tsorotes, et al.
Diabetes|October 29, 2002
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathyJosephine M Forbes, Mark E Cooper, Vicki Thallas, et al.
American Journal of Physiology. Renal Physiology|December 18, 2009
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathyAdeline L Y Tan, Karly C Sourris, Brooke E Harcourt, et al.
Clinical Science (London, England : 1979)|December 11, 2012
Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetesChris Tikellis, Raelene J Pickering, Despina Tsorotes, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathyJosephine M Forbes, Suzanne R Thorpe, Vicki Thallas-Bonke, et al.
Pageof 18